Shattuck Labs, Inc. (STTK) stock
STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.81−0.24 (-4.75%)
Close on Nov 12, 2026Market cap $482.75MP/E –Yield –
Shattuck Labs total assets
Total assets on the balance sheet at the end of each period.
Shattuck Labs's total assets was $207.98M at Sep 30, 2026. For fiscal 2025 it was $91.03M, down 0.0% from the year before. The highest annual figure on record is $348.99M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $91.03M | -0.0% |
| FY2024 | Dec 31, 2024 | $91.05M | -42.9% |
| FY2023 | Dec 31, 2023 | $159.56M | -22.3% |
| FY2022 | Dec 31, 2022 | $205.32M | -31.2% |
| FY2021 | Dec 31, 2021 | $298.59M | -14.4% |
| FY2020 | Dec 31, 2020 | $348.99M | +676.1% |
| FY2019 | Dec 31, 2019 | $44.97M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $207.98M | +107.3% |
| Q2 FY2026 | Jun 30, 2026 | $220.67M | +242.8% |
| Q1 FY2026 | Mar 31, 2026 | $102.12M | +32.3% |
| Q4 FY2025 | Dec 31, 2025 | $91.03M | -0.0% |
| Q3 FY2025 | Sep 30, 2025 | $100.33M | -10.2% |
| Q2 FY2025 | Jun 30, 2025 | $64.37M | -50.0% |
| Q1 FY2025 | Mar 31, 2025 | $77.17M | -47.3% |
| Q4 FY2024 | Dec 31, 2024 | $91.05M | -42.9% |
| Q3 FY2024 | Sep 30, 2024 | $111.72M | -14.4% |
| Q2 FY2024 | Jun 30, 2024 | $128.61M | -17.2% |
| Q1 FY2024 | Mar 31, 2024 | $146.34M | -17.6% |
| Q4 FY2023 | Dec 31, 2023 | $159.56M | -22.3% |
| Q3 FY2023 | Sep 30, 2023 | $130.46M | -41.5% |
| Q2 FY2023 | Jun 30, 2023 | $155.27M | -38.2% |
| Q1 FY2023 | Mar 31, 2023 | $177.68M | -34.3% |
| Q4 FY2022 | Dec 31, 2022 | $205.32M | -31.2% |
| Q3 FY2022 | Sep 30, 2022 | $222.94M | -28.2% |
| Q2 FY2022 | Jun 30, 2022 | $251.34M | -22.4% |
| Q1 FY2022 | Mar 31, 2022 | $270.49M | -19.7% |
| Q4 FY2021 | Dec 31, 2021 | $298.59M | -14.4% |
| Q3 FY2021 | Sep 30, 2021 | $310.57M | +114.4% |
| Q2 FY2021 | Jun 30, 2021 | $323.78M | +620.0% |
| Q1 FY2021 | Mar 31, 2021 | $336.85M | – |
| Q4 FY2020 | Dec 31, 2020 | $348.99M | – |
| Q3 FY2020 | Sep 30, 2020 | $144.86M | – |
| Q4 FY2019 | Dec 31, 2019 | $44.97M | – |
See a number that looks wrong?